This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive  Media Kit

Home   About   Scholarships   Meetings   Publications   Resources   September 22, 2015

 



CDC: This year's flu vaccine should be better match
HealthDay News
This year's flu vaccine should be a better match than last year's for circulating flu strains, U.S. health officials said. Dr. Tom Frieden, director of the U.S. Centers for Disease Control and Prevention, said that in most years, the vaccine is 50 to 60 percent effective, meaning that your odds of getting the flu are reduced by as much as 60 percent if you get a flu shot.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Compressive sensing could dramatically reduce time to process complex clinical laboratory tests involving huge amounts of data and lower the cost of tests
DARK Daily
Pathologists and medical laboratory managers may soon be working with a new tool in their labs. It is called compressive sensing, and it is an innovative mathematical approach that quickly and efficiently gets an answer by sampling large volumes of a data.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Old stem cell barriers fade away
Science News
Breaking down barriers usually sounds like a good thing, but not for aging stem cells. When young brain stem cells split in two, they can wall off damaged proteins in one daughter cell, leaving the other spry and ready to divide again, researchers report in the Sept. 18 Science.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Advance your degree!
- Completely Online MLT to Bachelor of Science in Clinical Laboratory   Science
- Remain in your current employment
- Individualized plans of study designed to fit your personal needs

Visit our website for more information, or contact the CLS program by Email or 402-559-6673.
 


Digital 'Rosetta Stone' decrypts how mutations rewire cancer cells
University of Copenhagen, Biotech Research & Innovation Centre via ScienceDaily
Scientists have discovered how genetic cancer mutations systematically attack the networks controlling human cells, knowledge critical for the future development of personalized precision cancer treatments. Since the human genome was decoded more than a decade ago, cancer genomics studies have dominated life science worldwide and have been extremely successful at identifying mutations in individual patients and tumors.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




New catalyst yields more accurate prostate cancer test
Lab Manager
Say you've been diagnosed with prostate cancer, the second-leading cause of cancer death in men. You opt for surgery to remove your prostate. Three months later, a prostate surface antigen test shows no prostate cells in your body. Everyone rejoices.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cancer remains leading cause of death among US Hispanics
Reuters
Cancer remains the leading cause of death among Hispanics in the U.S., driven in large part by lung malignancies in men and breast tumors in women, a new report finds. This year, Hispanics in the U.S. will experience 125,900 new cases of cancer and 37,800 deaths from cancer, the report predicts.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


E. coli more virulent when accompanied by beneficial bacteria
Pennsylvania State University via Infection Control Today
Scientists wonder why some people get so sick and even die after being infected by the foodborne pathogen E.coli, while others experience much milder symptoms and recover relatively quickly. Now Penn State's College of Agricultural Sciences researchers believe they have discovered an explanation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Easier HbA1c Linearity Testing
Maine Standards Company, LLC Launches VALIDATE® HbA1c For Easier Calibration Verification / Linearity Testing. VALIDATE® HbA1c is a liquid, easy-to-use kit that tests linearity for % Glycohemoglobin A1c in a human-whole-blood base matrix. VALIDATE® virtually eliminates dilutions while maximizing reportable ranges. Visit www.mainestandards.com or call 1-800-377-9684 for more information.
 


New gene linked to hereditary cancer of the colon identified
Health Canal
The study of 175 high-risk families has established a causal link between the gene FAN1 and the aggregation of hereditary colorectal cancer. This study has been published in the journal Gastroenterology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Genetic testing improves Type 2 diabetes risk assessment
Healio
The accuracy of Type 2 diabetes risk assessment in the general population could be improved with the implementation of genetic testing, according to research presented at the 51st European Association for the Study of Diabetes Annual Meeting. "Large-scale genome-wide association studies have revealed more than 80 genic loci associated with prevalent Type 2 diabetes, improving the understanding of molecular pathways leading to the disease," the researchers wrote.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Missed an issue of the eNewsBytes? Click here to visit the eNewsBytes archive page.


  FEATURED COMPANIES
Web-based competency testing
A powerful web-based program for proficiency testing of blood and body-fluid differentials. Instant access anywhere! Try it out FREE now. MORE
MT(AMT)
Wear it proudly! AMT certified members are knowledgeable, passionate and committed to providing quality healthcare. AMT members are lifelong learners. MORE


Scientists create 'protein patch' that repairs damage caused by heart attack
Medical News Today
Researchers have developed a "protein patch" that they say reversed damage to mouse and pig hearts caused by heart attack. The new creation could be set to enter human clinical trials as early as 2017.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Evidence for person-to-person transmission of Alzheimer's pathology (Scientific American)
Researchers reawaken sleeping HIV in patient cells to eliminate the virus (Sanford Burnham Prebys Medical Discovery Institute via Infection Control Today)
2nd death reported in nationwide salmonella outbreak (HealthDay News)
Pancreatic cancer stem cells could be 'suffocated' by an anti-diabetic drug (Queen Mary, University of London via ScienceDaily)

Don't be left behind. Click here to see what else you missed.
 



ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Katina Smallwood, Senior Editor, 469.420.2675   
Contribute news


This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Join ASCLS and we will subscribe you -- it's free!

Recent issues

Sept. 15, 2015
Sept. 9, 2015 Blast
Sept. 8, 2015
Sept. 1, 2015






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063